SEC filing · 8-K

Aquestive Therapeutics, Inc.: Executive or director change

Aquestive Therapeutics appointed Richard J. Daly to its Board of Directors effective October 14, 2026.

Filed September 29, 2026

Positive for the company

What happened

Aquestive Therapeutics announced the election of Richard J. Daly as a director, effective October 14, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Aquestive Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.